(Q33707601)

28 July 2017

1 reference

title

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives (English)

1 reference

28 July 2017

2

Holsboer F

1 reference

28 July 2017

Rupprecht R

1

1 reference

28 July 2017

publication date

1 September 1999

1 reference

28 July 2017

published in

Trends in Neurosciences

1 reference

28 July 2017

volume

22

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

410-416

1 reference

The steroid and thyroid hormone receptor superfamily

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

The neuropsychopharmacological potential of neuroactive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids and GABAA receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Non-genomic and genomic effects of steroids on neural activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Membrane sex-steroid receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

A corticosteroid receptor in neuronal membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Specific, nongenomic actions of steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Progesterone receptor-mediated effects of neuroactive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Specific subunit mRNAs of the GABAA receptor are regulated by progesterone in subfields of the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

The effects of steroid hormones on electrical activity of excitable cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids: a novel function of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids act on recombinant human GABAA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Cloning and functional expression of a Drosophila gamma-aminobutyric acid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Progesterone modulates a neuronal nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Mechanism underlying potentiation by progesterone of the kainate-induced current in cultured neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Inhibition of oxytocin receptor function by direct binding of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neurosteroids act on the GABA(A) receptor at sites on the N-terminal side of the middle of TM2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Dehydroepiandrosterone and its sulfate enhance memory retention in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Dehydroepiandrosterone sulfate in a long-term care aged population

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Assessment of neuroleptic-like properties of progesterone.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Role of tyrosine kinase pathways in ETB receptor activation of NHE3.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Progesterone therapy in women with complex partial and secondary generalized seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Do neuroactive steroids cause fatigue in pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Marked decrease of plasma neuroactive steroids during alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Effects of antidepressant treatment on neuroactive steroids in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2899%2901399-5

7 January 2021

10.1016/S0166-2236(99)01399-5

Identifiers

DOI

1 reference

28 July 2017

1 reference